NasdaqCM - BOATS Real Time Price USD

Tenon Medical, Inc. (TNON)

4.0400 -0.0500 (-1.22%)
At close: October 1 at 4:00:01 PM EDT
4.0100 -0.0300 (-0.74%)
Overnight: 1:14:24 AM EDT
Chart Range Bar
Loading chart for TNON
Chart does not reflect overnight price.
  • Previous Close 4.0900
  • Open 3.9900
  • Bid 2.9500 x 200
  • Ask 4.7200 x 200
  • Day's Range 3.6501 - 4.1700
  • 52 Week Range 2.4000 - 50.4000
  • Volume 2,032,325
  • Avg. Volume 6,394,564
  • Market Cap (intraday) 2.695M
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) --
  • EPS (TTM) -42.0200
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 44.38

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

www.tenonmed.com

26

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 10/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TNON
87.88%
S&P 500 (^GSPC)
11.99%

1-Year Return

TNON
90.54%
S&P 500 (^GSPC)
14.23%

3-Year Return

TNON
99.07%
S&P 500 (^GSPC)
78.79%

5-Year Return

TNON
99.99%
S&P 500 (^GSPC)
75.96%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 1.5M
Earnings -2.83M
Profit Margin -188.80%

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-3M
-2M
-1M
0
1M
-400.0%
-300.0%
-200.0%
 

Analyst Insights

View More

Analyst Price Targets

10.00
44.38 Average
4.0400 Current
78.75 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 4/9/2025
Analyst Alliance Global Partners
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 3
 

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    2.18M

  • Enterprise Value

    9.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.18

  • Price/Book (mrq)

    4.02

  • Enterprise Value/Revenue

    1.74

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -257.85%

  • Return on Assets (ttm)

    -71.98%

  • Return on Equity (ttm)

    -551.19%

  • Revenue (ttm)

    5.31M

  • Net Income Avi to Common (ttm)

    -13.7M

  • Diluted EPS (ttm)

    -42.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.68M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -6.12M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.0400 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch